Yüklüyor......
A96 ADALIMUMAB FOR MAINTENANCE OF REMISSION IN CROHN’S DISEASE
BACKGROUND: Maintenance of remission of Crohn’s disease (CD) is a clinically important goal, as disease relapse can negatively affect quality of life. AIMS: The objective of this systematic review was to assess the efficacy and safety of adalimumab for maintenance of remission in patients with quies...
Kaydedildi:
| Yayımlandı: | J Can Assoc Gastroenterol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512699/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.095 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|